BACKGROUND: A guideline is provided for the implementation of regional deep hyperthermia treatments under strict rules of quality assurance. The objective is to guarantee a comparable and comprehensible method in the treatment and scientific analysis of hyperthermia. The guideline describes regional deep hyperthermia (RHT) and MR-controlled partial body hyperthermia (PBH) of children, young and adult patients. According to this guideline, hyperthermia treatment is always applied in combination with chemotherapy and/or radiotherapy. METHODS: The guideline is based on practical experience from several hyperthermia centers. The procedure allows applying jointly coordinated standards and quality control in hyperthermia for studies. RESULTS: The guideline contains recommendations for hyperthermia treatments, including indication, preparation, treatment, and standardized analysis.
BACKGROUND: A guideline is provided for the implementation of regional deep hyperthermia treatments under strict rules of quality assurance. The objective is to guarantee a comparable and comprehensible method in the treatment and scientific analysis of hyperthermia. The guideline describes regional deep hyperthermia (RHT) and MR-controlled partial body hyperthermia (PBH) of children, young and adult patients. According to this guideline, hyperthermia treatment is always applied in combination with chemotherapy and/or radiotherapy. METHODS: The guideline is based on practical experience from several hyperthermia centers. The procedure allows applying jointly coordinated standards and quality control in hyperthermia for studies. RESULTS: The guideline contains recommendations for hyperthermia treatments, including indication, preparation, treatment, and standardized analysis.
Authors: Johanna Gellermann; Waldemar Wlodarczyk; Bert Hildebrandt; Hildegard Ganter; Anett Nicolau; Beate Rau; Wolfgang Tilly; Horst Fähling; Jacek Nadobny; Roland Felix; Peter Wust Journal: Cancer Res Date: 2005-07-01 Impact factor: 12.701
Authors: J Gellermann; W Wlodarczyk; A Feussner; H Fähling; J Nadobny; B Hildebrandt; R Felix; P Wust Journal: Int J Hyperthermia Date: 2005-09 Impact factor: 3.914
Authors: J van der Zee; D González González; G C van Rhoon; J D van Dijk; W L van Putten; A A Hart Journal: Lancet Date: 2000-04-01 Impact factor: 79.321
Authors: Pavel S Yarmolenko; Eui Jung Moon; Chelsea Landon; Ashley Manzoor; Daryl W Hochman; Benjamin L Viglianti; Mark W Dewhirst Journal: Int J Hyperthermia Date: 2011 Impact factor: 3.914
Authors: P Konstanczak; P Wust; B Sander; S Schründer; T Frenzel; W Wlodarczyk; T Vogl; G Müller; R Felix Journal: Strahlenther Onkol Date: 1997-02 Impact factor: 4.033
Authors: Edwin van der Wal; Martine Franckena; Dennis H M Wielheesen; Jacoba van der Zee; Gerard C van Rhoon Journal: Int J Hyperthermia Date: 2008-12 Impact factor: 3.914
Authors: Lifei Zhu; Michael B Altman; Andrei Laszlo; William Straube; Imran Zoberi; Dennis E Hallahan; Hong Chen Journal: Ultrasound Med Biol Date: 2019-02-14 Impact factor: 2.998
Authors: G Bruggmoser; S Bauchowitz; R Canters; H Crezee; M Ehmann; J Gellermann; U Lamprecht; N Lomax; M B Messmer; O Ott; S Abdel-Rahman; M Schmidt; R Sauer; A Thomsen; R Wessalowski; G van Rhoon Journal: Strahlenther Onkol Date: 2012-09 Impact factor: 3.621
Authors: A M Kukiełka; M Hetnał; P Brandys; T Walasek; T Dąbrowski; E Pluta; D Nahajowski; R Kudzia Journal: Strahlenther Onkol Date: 2013-04-20 Impact factor: 3.621